Next-Generation Sequencing For Adventitious Virus Detection Helps Speed Response To COVID-19
It's another case where the pandemic spurs adoption of ways to speed the manufacture of vaccines and biologics that have been in development for years.
You may also be interested in...
Emerging global standard could speed testing of biologics and gene therapies for stray viral particles, while sparing laboratory animals.
New draft document addresses issues with applying quality-by-design to gene therapies, accommodating the Common Technical Document format, as well as drug substance, cell bank and contract manufacturing issues. US FDA's Denise Gavin offers insights on agency thinking at gene therapy conference.
Viral contamination in one of the plant's bioreactors caused a complete shutdown, stopping new production of Cerezyme and Fabrazyme.